Vaccine
Found 4 recent publications
Could the Shingles Vaccine Help Protect Against Dementia?
Recent studies from Stanford and Oxford universities suggest a potential link between the shingles vaccine and a lowered risk of dementia, driving a surge in vaccination demand across pharmacies in the UK.
Breakthrough for Moderna and Merck: Promising Results in Advanced Melanoma Vaccine Trial
An experimental personalized cancer vaccine from Merck and Moderna has shown positive preliminary results in a Phase 3 trial. The combination therapy significantly reduced the risk of melanoma recurrence.
Breakthrough for Moderna and Merck: Promising results in advanced melanoma vaccine trial
An experimental personalized cancer vaccine for melanoma from Merck and Moderna has shown positive preliminary results in its first late-stage trial. The combination therapy significantly extended the time patients lived without recurrence.
After decades: A new flu vaccine has been approved that may change the rules of the game
The US Food and Drug Administration (FDA) has approved Moderna's Mfalusiva, the first seasonal flu vaccine based on mRNA technology. In a large-scale trial, the vaccine showed a 26.6% higher relative efficacy compared to a standard-dose flu vaccine.